SAN DIEGO, April 25, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (NASDAQ: OREX) will announce corporate and financialresults for the first quarter 2017 on Tuesday, May 9th after the market closes. Following the announcement, Orexigen will provide a business update and discuss the financial results in a live webcast and conference
The live call may be accessed by phone by calling (800) 708-4540 (domestic) or (847) 619-6397 (international), participant code 44748374. The webcast can be accessed live on the "Investors" section of the Orexigen web site at www.orexigen.com, and will be archived for 14 days following the call.
Jason KeyesChief Financial OfficerOrexigen Therapeutics, Inc. +firstname.lastname@example.org
Media Contact: Erika HackmannY&Remail@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-and-discuss-first-quarter-2017-financial-results-on-may-9-2017-300445666.html
SOURCE Orexigen Therapeutics, Inc.
Subscribe to our Free Newsletters!
A patient's struggle with Issacs' syndrome with no cure. Also known as neuromyotonia it is a rare ...
Inguinal hernia surgery is a procedure to repair a weak spot or defect in the lower wall of the ...
Hypopituitarism is a rare disorder resulting from decreased secretion of one or more of the ...View All